Literature DB >> 2643051

The regulation of investigational drugs.

D A Kessler1.   

Abstract

Mesh：

Year:  1989        PMID： 2643051     DOI： 10.1056/NEJM198902023200504

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Cognition-enhancing drugs.

Authors:  Maxwell J Mehlman
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

Review 2.  The implications for Europe of revised FDA guidelines for clinical trials with anti-infective agents.

Authors:  D N Gilbert; T R Beam; C M Kunin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-07       Impact factor: 3.267

3.  Regulatory implications of good clinical practice. Towards harmonisation.

Authors:  E F Hvidberg
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

4.  Good clinical practice: a way to better drugs.

Authors:  E F Hvidberg
Journal:  BMJ       Date:  1989-09-02

Review 5.  The introduction of new drugs into anaesthetic practice: a perspective in pharmaceutical development and regulation.

Authors:  I Gilron
Journal:  Can J Anaesth       Date:  1995-06       Impact factor: 5.063

6.  When science and passion meet: the impact of AIDS on research.

Authors:  J Pripstein
Journal:  CMAJ       Date:  1993-02-15       Impact factor: 8.262

7.  The HA-1A saga: the scientific and ethical dilemma of innovative and costly therapies.

Authors:  C Brun-Buisson
Journal:  Intensive Care Med       Date:  1994-05       Impact factor: 17.440
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.